SEC Form 4 · accession 0001171843-17-000584
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dana M. Alexander
Officer — Chief Operations Officer
Period of report
Jan 27, 2017
Accepted (ET)
Jan 31, 2017 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $50.13 | Jan 27, 2017 | A | 16,875 | A | — | Jan 27, 2027 | Common Stock | 16,875 | 16,875 | D |
Explanation of responses
- F1The stock options vest in three equal annual installments beginning January 27, 2018.